Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This House Resolution expresses the sense of the House of Representatives that over 25 years of evidence and numerous peer-reviewed studies demonstrate mifepristone’s safety and effectiveness as a medication for abortion. It calls for law and policy governing access to this medication to be based on transparent, evidence-based science and to avoid imposing unnecessary burdens on patients. The resolution also highlights the importance of equitable access to medication abortion, particularly for marginalized communities.
Key provisions
- The FDA’s policies regarding mifepristone should be based on transparent scientific review and consideration of patient access.
- Congress has authority to regulate prescription drugs based on scientific determinations of safety and efficacy.
- The FDA has repeatedly found mifepristone to be safe and effective over 25 years of reviews.
- Preserving access to medication abortion, including telemedicine prescriptions and mail-order dispensing, is crucial.
- Efforts to restrict mifepristone access should be opposed.
- The resolution emphasizes the need for equitable access to abortion care for marginalized communities.
Who is affected
- Patients seeking abortion care
- Healthcare providers
- The Food and Drug Administration
- Black and Indigenous people
- People of color
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
54 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours